Opportunity Information: Apply for CDC RFA PS12 120803CONT14
Apply for CDC RFA PS12 120803CONT14
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Serve as the U.S. partner within the global STOP TB Partnership and participate in Stop TB Partnership activities" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.947 Tuberculosis Demonstration, Research, Public and Professional Education.
- This funding opportunity was created on Mar 18, 2014 and posted on Mar 18, 2014.
- Applicants must submit their applications by Apr 22, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 50 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- This award will be a continuation of funds intended only for grantees previously awarded under CDC RFA PS12 1208 Serve as the U.S. partner within the global STOP TB Partnership and participate in Stop TB Partnership activities.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
This funding opportunity, listed as CDC RFA PS12-120803CONT14, is a Centers for Disease Control and Prevention (CDC) cooperative agreement focused on maintaining a U.S.-based partner role within the global STOP TB Partnership and taking part in the Partnership's activities. The core purpose is not to launch a brand-new program, but to continue ongoing work that supports international collaboration around tuberculosis (TB) prevention, control, research, education, and related capacity-building efforts tied to the STOP TB Partnership framework. Because it is structured as a cooperative agreement, the CDC would typically be expected to have an active role beyond simple pass-through funding, with substantial federal involvement in planning, coordination, or oversight consistent with cooperative agreement practices.
The opportunity is explicitly categorized as continuation funding, meaning eligibility is limited. It is intended only for organizations that were previously awarded under the earlier related announcement, CDC RFA PS12-1208, which covered the same scope: serving as the U.S. partner within the STOP TB Partnership and participating in Partnership activities. In practical terms, this makes the applicant pool narrow and pre-defined, since new applicants without an existing award under the predecessor funding announcement would not be eligible for this continuation.
From a programmatic standpoint, the activities supported by this award revolve around engagement with the STOP TB Partnership as the U.S. partner, which generally implies representing U.S. perspectives and technical strengths, coordinating with global stakeholders, and contributing to Partnership-led initiatives, meetings, technical workstreams, and other collaborative efforts aimed at reducing TB burden worldwide. The funding is connected to CFDA 93.947 (Tuberculosis Demonstration, Research, Public and Professional Education), signaling that the supported work aligns with TB-related demonstration projects, research-related engagement, and education/outreach to public and professional audiences as part of broader TB control strategies.
Administratively, the announcement was posted and created on March 18, 2014, with an original and current closing date of April 22, 2014, and an archive date of May 22, 2014. The opportunity lists an expected number of awards as 50, and it notes a cost sharing or matching requirement, meaning the funded entity would be expected to contribute non-federal resources toward the project as a condition of the award. The estimated total funding amount is shown as 0 in the listing, which can occur in government postings when the dollar figure is not displayed in the summary record or is handled through continuation increments rather than a newly stated total.
Eligible applicants are shown as "Others (see text field entitled Additional Information on Eligibility for clarification)," but the key clarification provided is that this is continuation funding restricted to prior grantees under the earlier CDC RFA PS12-1208 award. The agency administering the opportunity is the CDC. For access issues or support related to the full announcement, the listing provides the CDC Procurement and Grants Office (PGO) contact details: phone 770-488-2700 and email pgotim@cdc.gov.
FAQs: CDC RFA PS12-120803CONT14 (STOP TB Partnership U.S. Partner - Continuation)
What is the funding opportunity number for this grant?
The opportunity is listed as CDC RFA PS12-120803CONT14.
Which federal agency is offering this opportunity?
The administering agency is the Centers for Disease Control and Prevention (CDC).
What type of award is this (grant vs. cooperative agreement)?
This opportunity is a CDC cooperative agreement. That structure typically means CDC expects to have substantial involvement beyond pass-through funding, such as active participation in planning, coordination, and/or oversight consistent with cooperative agreement practices.
What is the main purpose of this cooperative agreement?
The purpose is to maintain a U.S.-based partner role within the global STOP TB Partnership and to participate in the Partnership's activities that support international collaboration around tuberculosis (TB) prevention, control, research, education, and related capacity-building efforts.
Is this funding meant to start a brand-new program?
No. The core purpose is continuation of ongoing work, not launching a brand-new program.
What does "continuation funding" mean for this announcement?
This is explicitly categorized as continuation funding, which limits eligibility to organizations that previously received an award under the earlier related announcement (CDC RFA PS12-1208) covering the same scope.
Who is eligible to apply?
Eligibility is restricted to prior grantees under the earlier CDC RFA PS12-1208 award. The listing also shows eligible applicants as "Others (see text field entitled Additional Information on Eligibility for clarification)," with the key clarification being that only previous awardees under PS12-1208 may apply.
Can new organizations apply if they were not funded under CDC RFA PS12-1208?
No. Based on the description, new applicants without an existing award under the predecessor announcement (CDC RFA PS12-1208) are not eligible for this continuation funding.
What kinds of activities are supported under this award?
Supported activities focus on engagement with the STOP TB Partnership as the U.S. partner. This generally includes representing U.S. perspectives and technical strengths, coordinating with global stakeholders, and contributing to Partnership-led initiatives, meetings, technical workstreams, and other collaborative efforts aimed at reducing TB burden worldwide.
What is the STOP TB Partnership connection in this opportunity?
The award is specifically intended to maintain a U.S.-based partner role within the global STOP TB Partnership and to support participation in Partnership activities.
What CFDA program is associated with this funding?
The opportunity is connected to CFDA 93.947 (Tuberculosis Demonstration, Research, Public and Professional Education).
What does CFDA 93.947 suggest about the project focus?
It signals alignment with TB-related demonstration projects, research-related engagement, and education/outreach to public and professional audiences as part of broader TB control strategies, as described in the listing.
When was the opportunity posted?
The announcement was posted and created on March 18, 2014.
What is the application deadline?
The original and current closing date is April 22, 2014.
When was the opportunity archived?
The archive date is May 22, 2014.
How many awards does the opportunity expect to make?
The listing shows an expected number of awards as 50.
Is there a cost sharing or matching requirement?
Yes. The opportunity notes a cost sharing or matching requirement, meaning the funded entity is expected to contribute non-federal resources as a condition of the award.
How much total funding is available?
The estimated total funding amount is shown as 0 in the listing. The summary notes that this can happen in government postings when the dollar figure is not displayed in the summary record or when funds are handled through continuation increments rather than a newly stated total.
Who should be contacted for access issues or support related to the full announcement?
The listing provides the CDC Procurement and Grants Office (PGO) as the contact point. Phone: 770-488-2700. Email: pgotim@cdc.gov.
Browse more opportunities from the same category: Health
Next opportunity: BioSense 2.0 Building State, Local, Tribal, and Territorial Surveillance Capacity to Enhance Regional and National All Hazards Public Health Situation Awareness Center for Surveillance, Epidemiology and Laboratory Services
Previous opportunity: BLM CO Noxious Weed Management in Rio Blanco County Colorado.
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS12 120803CONT14
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS12 120803CONT14) also looked into and applied for these:
| Funding Opportunity |
|---|
| BioSense 2.0 Building State, Local, Tribal, and Territorial Surveillance Capacity to Enhance Regional and National All Hazards Public Health Situation Awareness Center for Surveillance, Epidemiology and Laboratory Services Apply for CDC RFA OE12 120203CONT14 Funding Number: CDC RFA OE12 120203CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Family Planning, Maternal, Neonatal and Child Health (FP/MNCH) Project in Afghanistan Apply for SOL 306 14 00226 Funding Number: SOL 306 14 00226 Agency: Afghanistan USAID Kabul Category: Health Funding Amount: $55,000,000 |
| Global Non Communicable Disease Prevention and Promotion of Health Apply for CDC RFA GH14 1420 Funding Number: CDC RFA GH14 1420 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Human Immunodeficiency Virus (HIV) Prevention Projects for Young Men of Color Who Have Sex with Men (YMSM of Color) and Apply for CDC RFA PS11 111304CONT14 Funding Number: CDC RFA PS11 111304CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Atopic Dermatitis Research Network (ADRN) (U19) Apply for RFA AI 14 033 Funding Number: RFA AI 14 033 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Translational Research to Help Older Adults Maintain their Health and Independence in the Community (R21) Apply for PA 14 159 Funding Number: PA 14 159 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| Translational Research to Help Older Adults Maintain their Health and Independence in the Community (R01) Apply for PA 14 161 Funding Number: PA 14 161 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Girls Education Strengthen Family and Community Support to Orphans and Vulnerable Children Program Apply for RFA 656 14 000001 Funding Number: RFA 656 14 000001 Agency: Mozambique USAID Maputo Category: Health Funding Amount: $15,864,752 |
| Population based HIV Impact Assessments in Resource Constrained Settings under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH14 1409 Funding Number: CDC RFA GH14 1409 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $25,000,000 |
| Rural Access to Emergency Devices Grant Program Apply for HRSA 14 129 Funding Number: HRSA 14 129 Agency: Health Resources and Services Administration Category: Health Funding Amount: $150,000 |
| Public Access to Defibrillation Demonstration Project Apply for HRSA 14 130 Funding Number: HRSA 14 130 Agency: Health Resources and Services Administration Category: Health Funding Amount: $150,000 |
| Mali High Impact Health Services II Apply for RFA 688 14 000005 Funding Number: RFA 688 14 000005 Agency: Mali USAID Bamako Category: Health Funding Amount: $45,000,000 |
| Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus Network Leadership Center (UM2) Apply for RFA AR 14 015 Funding Number: RFA AR 14 015 Agency: National Institutes of Health Category: Health Funding Amount: $2,000,000 |
| Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus Network Research Sites (UH2/UH3) Apply for RFA AR 14 016 Funding Number: RFA AR 14 016 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Modeling Immunity for Biodefense (U19) Apply for RFA AI 14 028 Funding Number: RFA AI 14 028 Agency: National Institutes of Health Category: Health Funding Amount: $1,000,000 |
| CDCs National Undergraduate Student Program A Public Helath Workplace Experience to Increase Student Interest in Public Health Apply for CDC RFA MN11 110104CONT14 Funding Number: CDC RFA MN11 110104CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Building Capacity and Networks to Address Emerging Infectious Diseases in the Americas Apply for CDC RFA CK13 130102CONT14 Funding Number: CDC RFA CK13 130102CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Leveraging a Recovery Act Resource to Accelerate Research on Neurodevelopment (R01) Apply for RFA MH 15 400 Funding Number: RFA MH 15 400 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Provider Education and Public Awareness about Primary Immunodeficiency Disease Apply for CDC RFA OE12 120303CONT14 Funding Number: CDC RFA OE12 120303CONT14 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
| Targeting Latently Infected Cells Without Reactivation (R01) Apply for RFA AI 14 021 Funding Number: RFA AI 14 021 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS12 120803CONT14", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.